These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18029074)
1. Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats. Egashira N; Ishigami N; Mishima K; Iwasaki K; Oishi R; Fujiwara M Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):499-506. PubMed ID: 18029074 [TBL] [Abstract][Full Text] [Related]
2. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880 [TBL] [Abstract][Full Text] [Related]
3. Involvement of opioid system in cognitive deficits induced by ∆⁹-tetrahydrocannabinol in rats. Egashira N; Manome N; Mishima K; Iwasaki K; Oishi R; Fujiwara M Psychopharmacology (Berl); 2012 Feb; 219(4):1111-8. PubMed ID: 21858449 [TBL] [Abstract][Full Text] [Related]
4. Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments. Zhang C; Fang Y; Xu L Schizophr Res; 2014 Nov; 159(2-3):376-84. PubMed ID: 25219486 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats. Mishima K; Egashira N; Hirosawa N; Fujii M; Matsumoto Y; Iwasaki K; Fujiwara M Jpn J Pharmacol; 2001 Dec; 87(4):297-308. PubMed ID: 11829149 [TBL] [Abstract][Full Text] [Related]
6. The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats. Inui K; Egashira N; Mishima K; Yano A; Matsumoto Y; Hasebe N; Abe K; Hayakawa K; Ikeda T; Iwasaki K; Fujiwara M Neurotox Res; 2004; 6(2):153-8. PubMed ID: 15325968 [TBL] [Abstract][Full Text] [Related]
7. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Shirazi-Southall S; Rodriguez DE; Nomikos GG Neuropsychopharmacology; 2002 May; 26(5):583-94. PubMed ID: 11927183 [TBL] [Abstract][Full Text] [Related]
8. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Young JM; McGregor IS; Mallet PE Neuropsychopharmacology; 2005 Aug; 30(8):1475-82. PubMed ID: 16178074 [TBL] [Abstract][Full Text] [Related]
9. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex. Rodrigues LC; Conti CL; Nakamura-Palacios EM Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Nava F; Carta G; Colombo G; Gessa GL Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice. Hou Y; Wu CF; Yang JY; Guo T Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1486-95. PubMed ID: 16842896 [TBL] [Abstract][Full Text] [Related]
12. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats. Ortega-Alvaro A; Gibert-Rahola J; Micó JA Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):104-11. PubMed ID: 16226364 [TBL] [Abstract][Full Text] [Related]
13. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Rubino T; Realini N; Braida D; Guidi S; Capurro V; Viganò D; Guidali C; Pinter M; Sala M; Bartesaghi R; Parolaro D Hippocampus; 2009 Aug; 19(8):763-72. PubMed ID: 19156848 [TBL] [Abstract][Full Text] [Related]
14. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Nagai T; Takuma K; Dohniwa M; Ibi D; Mizoguchi H; Kamei H; Nabeshima T; Yamada K Psychopharmacology (Berl); 2007 Sep; 194(1):21-32. PubMed ID: 17514479 [TBL] [Abstract][Full Text] [Related]
15. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. D'Souza DC; Braley G; Blaise R; Vendetti M; Oliver S; Pittman B; Ranganathan M; Bhakta S; Zimolo Z; Cooper T; Perry E Psychopharmacology (Berl); 2008 Jul; 198(4):587-603. PubMed ID: 18228005 [TBL] [Abstract][Full Text] [Related]
16. The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats. Mishima K; Iwasaki K; Tsukikawa H; Matsumoto Y; Egashira N; Abe K; Egawa T; Fujiwara M Jpn J Pharmacol; 2000 Oct; 84(2):163-73. PubMed ID: 11128039 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours. Onaolapo OJ; Paul TB; Onaolapo AY Metab Brain Dis; 2017 Oct; 32(5):1475-1489. PubMed ID: 28508340 [TBL] [Abstract][Full Text] [Related]
19. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application. Fujiwara M; Egashira N J Pharmacol Sci; 2004 Dec; 96(4):362-6. PubMed ID: 15599103 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]